当前推荐的产前维生素D补充与胎儿生长:中国安徽出生队列研究结果
在中国安徽出生队列中,孕期常规建议每日补充600 IU维生素D3,1491名新生儿按母亲补充时长分组。母亲补充超过2个月者,脐血25(OH)D中位数37.9 nmol/L,比未补充者34.3 nmol/L高3.5 nmol/L(95%CI 0.8-6.2);小于胎龄儿风险11.8% vs 6.9%,校正OR=0.53(95%CI 0.32-0.87)。
要点
- 孕期补充维生素D超过2个月,新生儿脐血25(OH)D较未补充者高3.5 nmol/L(95%CI 0.8-6.2)。
- 补充超过2个月者小于胎龄儿风险11.8% vs 未补充者6.9%,校正OR=0.53(95%CI 0.32-0.87)。
- 脐血25(OH)D差异不受出生季节影响。
核心结论
- 中国研究提示,按IOM推荐补充维生素D可使胎儿25(OH)D水平略有但显著升高,并改善胎儿生长。
研究设计与样本
- 中国安徽出生队列研究,前瞻性收集母亲社会人口学特征、食物摄入、生活方式、维生素D补充信息及出生结局。
- 孕期常规建议每日补充600 IU维生素D3。
- 测定1491名新生儿脐血25(OH)D、钙和磷,按母亲孕期补充维生素D时长分为三组。
主要发现
- 母亲孕期补充维生素D超过2个月的新生儿脐血25(OH)D中位数37.9 nmol/L,未补充者中位数34.3 nmol/L,前者高3.5 nmol/L(95%CI 0.8-6.2)。
- 脐血25(OH)D的显著差异不受出生季节影响。
- 补充超过2个月者小于胎龄儿风险11.8% vs 未补充者6.9%,校正OR=0.53(95%CI 0.32-0.87)。
关键数值与推荐
- 孕期常规建议每日补充600 IU维生素D3。
- 补充超过2个月者小于胎龄儿校正OR=0.53(95%CI 0.32-0.87)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Maternal vitamin D insufficiency has been associated with fetal growth restriction. However, the effect of maternal vitamin D supplementation on fetal growth has not been confirmed. OBJECTIVE: To assess the effect of maternal vitamin D supplementation recommended by the Institute of Medicine (IOM) during pregnancy on the neonatal vitamin D status and the risk of small for gestational age (SGA). DESIGN AND PARTICIPANTS: As part of the China-Anhui Birth Cohort study, maternal sociodemographic characteristics, food intake, lifestyle, information on vitamin D supplementation, and birth outcomes were prospectively collected. For participants, 600 IU/d of vitamin D3 was routinely advised to take during pregnancy. Cord blood levels of 25-hydroxyvitamin D [25(OH)D], calcium, and phosphorus were measured in 1491 neonates who were divided into three groups based on the duration of maternal vitamin D supplementation during pregnancy. RESULTS: Mean cord blood concentrations of 25(OH)D were 3.5 nmol/L higher [95% confidence interval (CI), 0.8, 6.2] in neonates (median, 37.9 nmol/L) whose mother took vitamin D supplementation for >2 months during pregnancy compared with those (median, 34.3 nmol/L) whose mother did not take any supplement. These significant differences on cord blood concentrations of 25(OH)D occurred regardless of the season of birth. The adjusted risk of SGA in pregnant women with vitamin D supplementation for >2 months was significantly decreased than that in women without any vitamin D supplementation (11.8% vs 6.9%; adjusted odds ratio = 0.53; 95% CI, 0.32, 0.87). CONCLUSIONS: The findings from China suggest that maternal vitamin D supplementation recommended by the IOM results in a slight but significantly higher fetal level of 25(OH)D and improves fetal growth.
引用
- Tao RX, Meng DH, Li JJ, et al. Current Recommended Vitamin D Prenatal Supplementation and Fetal Growth: Results From the China-Anhui Birth Cohort Study. J Clin Endocrinol Metab. 2018. PMID: 29096022. doi:10.1210/jc.2017-00850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。